Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
Launched by JOHNS HOPKINS UNIVERSITY · Oct 11, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring two ways to monitor diabetic foot ulcers, which are wounds that can develop on the feet of people with diabetes. The researchers want to see if using a smartphone app to track the healing of these wounds from home is as effective as regular in-person check-ups at a clinic. They will include 120 patients from a diabetic foot clinic in Baltimore, Maryland, who have active foot ulcers. Participants will be randomly assigned to either use the smartphone app for 12 weeks or receive standard in-person monitoring.
To be eligible for this study, participants must be at least 18 years old, currently receiving treatment for a diabetic foot ulcer, and able to use a smartphone to take pictures of their wound. However, those with very large wounds or those who can't access their wounds without help may not qualify. If you join the study, you can expect to monitor your healing using the app or through clinic visits, and this research aims to find out which method works better for patients like you.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male or female, aged ≥ 18 years old
- • In treatment for lower extremity wound related to diabetic foot ulcer
- • Able and willing to use a smartphone to assess the wound for the duration of the study
- • English language proficiency
- Exclusion Criteria:
- • Patients with less than 1 dressing change per week
- • Patients with wound size that cannot be covered with a single app scan (out of boundary conditions include wounds that wrap around patient's entire leg)
- • Patients with wounds in an inaccessible location who live without a caregiver to assist in taking wound scans
About Johns Hopkins University
Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Patients applied
Trial Officials
Caitlin Hicks, MD
Principal Investigator
Johns Hopkins School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials